Effective from
- Inherited rules changed
Encounter for screening for malignant neoplasms
Category — select a more specific code
CDC/NCHS · FY2026code to identify any family history of malignant neoplasm (Z80.-)
encounter for diagnostic examination-code to sign or symptom
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2026
Effective from
Encounter for screening for malignant neoplasms
Category — select a more specific code
CDC/NCHS · FY2026| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | Inherited rules changed |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
encounter for diagnostic examination-code to sign or symptom
code to identify any family history of malignant neoplasm (Z80.-)
Z12.0Encounter for screening for malignant neoplasm of stomachBillable / specificZ12.1Encounter for screening for malignant neoplasm of intestinal tractCategory · further specificity requiredZ12.2Encounter for screening for malignant neoplasm of respiratory organsBillable / specificZ12.3Encounter for screening for malignant neoplasm of breastCategory · further specificity requiredZ12.4Encounter for screening for malignant neoplasm of cervixBillable / specificZ12.5Encounter for screening for malignant neoplasm of prostateBillable / specificZ12.6Encounter for screening for malignant neoplasm of bladderBillable / specificZ12.7Encounter for screening for malignant neoplasm of other genitourinary organsCategory · further specificity requiredZ12.8Encounter for screening for malignant neoplasm of other sitesCategory · further specificity requiredZ12.9Encounter for screening for malignant neoplasm, site unspecifiedBillable / specificOfficial titles and instructions are preserved in their source language. Official sources ↗
Excludes 2 · screening for malignant neoplasms (Z12.-)